Fig. 2From: Acetyl-CoA metabolism drives epigenome change and contributes to carcinogenesis risk in fatty liver diseaseA Average number of cells with high ɣH2AX after oleic acid or oleic acid plus metabolic inhibitor drug treatments (% compared to control cells). B Representative ɣH2AX immunofluorescence images of control and oleic acid-treated cells (blue nuclear stain, pink ɣH2AX). Error bars are ± SEM. All groups n = 6–8. *P < 0.05, ***P < 0.0001 in t-test of oleic vs oleic plus inhibitor groupsBack to article page